Angiotensin-converting enzyme 2 A1075G polymorphism is associated with survival in an acute coronary syndromes cohort

American Heart Journal

Volumn 156, Issue 4, 2008, Pages 752-758

  Palmer, Barry R ^a   Jarvis, Martin D ^a   Pilbrow, Anna P ^a   Ellis, Katrina L ^a   Frampton, Chris M ^a   Skelton, Lorraine ^a   Yandle, Tim G ^a   Doughty, Rob N ^b   Whalley, Gillian A ^b   Ellis, Chris J ^b   Troughton, Richard W ^a   Richards, A Mark ^a   Cameron, Vicky A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN CONVERTING ENZYME 2 A1075G; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; CREATINE KINASE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; UNCLASSIFIED DRUG;

ACE2 GENE; ACUTE CORONARY SYNDROME; ADULT; AGED; ALLELE; ARTICLE; COHORT ANALYSIS; DIASTOLE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ENZYME POLYMORPHISM; ETHNICITY; EUROPE; FEMALE; FOLLOW UP; GENE; GENE LOCATION; GENOTYPE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE FILLING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MAORI; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL; X CHROMOSOME; X CHROMOSOME LINKAGE;

ACUTE CORONARY SYNDROME; AGED; ALLELES; COHORT STUDIES; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 52949141126     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.06.013     Document Type: Article

References (31)

1. Bernard V., Pillois X., Dubus I., et al. The -308 G/A tumor necrosis factor-alpha gene dimorphism: a risk factor for unstable angina. Clin Chem Lab Med 41 (2003) 511-516
2. Methot J., Hamelin B.A., Bogaty P., et al. ACE-DD genotype is associated with the occurrence of acute coronary syndrome in postmenopausal women. Int J Cardiol 105 (2005) 308-314
3. Arroyo-Espliguero R., El-Sharnouby K., Vazquez-Rey E., et al. CD14 C(-260)T promoter polymorphism and prevalence of acute coronary syndromes. Int J Cardiol 98 (2005) 307-312
4. Dedoussis G.V., Panagiotakos D.B., Vidra N.V., et al. Association between TNF-alpha -308G>A polymorphism and the development of acute coronary syndromes in Greek subjects: the CARDIO2000-GENE Study. Genet Med 7 (2005) 411-416
5. Iwai N., Shimoike H., Nakamura Y., et al. The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes. Atherosclerosis 136 (1998) 109-114
6. Leone A.M., De Stefano V., Burzotta F., et al. Glycoprotein Ia C807T gene polymorphism and increased risk of recurrent acute coronary syndromes: a five year follow up. Heart 90 (2004) 567-569
7. Donoghue M., Hsieh F., Baronas E., et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87 (2000) E1-E9
8. Tipnis S.R., Hooper N.M., Hyde R., et al. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275 (2000) 33238-33243
9. Keidar S., Kaplan M., and Gamliel-Lazarovich A. ACE2 of the heart: from angiotensin I to angiotensin (1-7). Cardiovasc Res 73 (2007) 463-469
10. Ferreira A.J., and Raizada M.K. Are we poised to target ACE2 for the next generation of antihypertensives?. J Mol Med 86 (2008) 685-690
11. Harmer D., Gilbert M., Borman R., et al. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Letters 532 (2002) 107-110
12. Crackower M.A., Sarao R., Oudit G.Y., et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417 (2002) 822-828
13. Benjafield A.V., Wang W.Y., and Morris B.J. No association of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension. Am J Hypertens 17 (2004) 624-628
14. Zhong J., Yan Z., Liu D., et al. Association of angiotensin-converting enzyme 2 gene A/G polymorphism and elevated blood pressure in Chinese patients with metabolic syndrome. J Lab Clin Med 147 (2006) 91-95
15. Yang W., Huang W., Su S., et al. Association study of ACE2 (angiotensin I-converting enzyme 2) gene polymorphisms with coronary heart disease and myocardial infarction in a Chinese Han population. Clin Sci (Lond) 111 (2006) 333-340
16. Niu W., Qi Y., Hou S., et al. Correlation of angiotensin-converting enzyme 2 gene polymorphisms with stage 2 hypertension in Han Chinese. Transl Res 150 (2007) 374-380
17. Lieb W., Graf J., Gotz A., et al. Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men. Results of the MONICA Augsburg echocardiographic substudy. J Mol Med 84 (2006) 88-96
18. Wang S.X., Fu C.Y., Zou Y.B., et al. Polymorphisms of angiotensin-converting enzyme 2 gene associated with magnitude of left ventricular hypertrophy in male patients with hypertrophic cardiomyopathy. Chin Med J (Engl) 121 (2008) 27-31
19. de Lemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
20. Sahn D.J., DeMaria A., Kisslo J., et al. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58 (1978) 1072-1083
21. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
22. Oh J.K., Appleton C.P., Hatle L.K., et al. The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 10 (1997) 246-270
23. Ommen S.R., Nishimura R.A., Appleton C.P., et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 102 (2000) 1788-1794
24. Palmer B., Pilbrow A., Frampton C., et al. ACE gene polymorphism interacts with LVEF and BNP levels to predict mortality following myocardial infarction. J Am Coll Cardiol 41 (2003) 729-736
25. Richards A., Nicholls M., Yandle T., et al. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. Heart 81 (1999) 114-120
26. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
27. Der Sarkissian S., Grobe J.L., Yuan L., et al. Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology. Hypertension 51 (2008) 712-718
28. Consortium T.I.H. The International HapMap Project. Nature 426 (2003) 789-796
29. Su B., Jin L., Underhill P., et al. Polynesian origins: insights from the Y chromosome. Proc Natl Acad Sci 97 (2000) 8225-8228
30. Diamond J.M. Linguistics: Taiwan's gift to the world. Nature 403 (2000) 709-710
31. Underhill P.A., Passarino G., Lin A.A., et al. Maori origins, Y-chromosome haplotypes and implications for human history in the Pacific. Hum Mutat 17 (2001) 271-280